SANUWAVE Health (SANUWAVE Health) Change In Working Capital

: $2.70 Mil (TTM As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

SANUWAVE Health's change in working capital for the quarter that ended in Dec. 2023 was $4.59 Mil.

SANUWAVE Health's change in working capital for the fiscal year that ended in Dec. 2023 was $2.70 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

SANUWAVE Health Change In Working Capital Historical Data

The historical data trend for SANUWAVE Health's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

1.70

1.37

9.93

-1.12

2.70

SANUWAVE Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital																1.28	2.20	-2.31	-1.79	4.59

SANUWAVE Health Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.70 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

SANUWAVE Health Change In Working Capital Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

SANUWAVE Health (SANUWAVE Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

11495 Valley View Road, Eden Prairie, MN, USA, 30024

Website

https://www.sanuwave.com

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Executives

Andrew Walko	officer: President	11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
James E Besser	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p.	director, other: Director by Deputization	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank	director	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	director, other: Director by Deputization	3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price	director	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh	officer: President	3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii	10 percent owner	200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski	director	99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc.	director	3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom	officer: Interim CFO	11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli	director, officer: Chief Executive Officer	510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins	officer: Chief Financial Officer	11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino	director	PO BOX 376, LOBBY L., ANN ARBOR MI 48105